NOVABAY PHARMACEUTICALS INC (NBY)       0.11  0 (0%)

0.11  0 (0%)

US66987P2011 - Common Stock - After market: 0.1079 0 (-1.91%)

Buy % Consensus

83
Analysts have set a mean price target of 2.86. This target is 2496.36% above the current price.
NBY was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NBY.
In the previous month the buy percentage consensus was at a similar level.
NBY was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 0.111.872.862.863.94 - 1,598.64% 2,496.36% 2,496.36% 3,479.55%

Up and Down Grades

Date Firm Action Rating
2022-05-20 Ascendiant Capital Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA